Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,511 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05954741Recruiting
Rehab program to improve thinking in recent vascular memory problems
This trial tests a structured, multi-part rehabilitation program to help people with early dementia symptoms from vascular or mixed causes. If you qualify, you may be offered the rehab program and compared with another approach to see if thinking and daily function improve.
Montescano, PaviaAges 65–80 - NCT05974995Recruiting
Robotic or standard surgery for early uterine cancer in obesity
This trial compares robotic-assisted surgery versus standard laparoscopic surgery for people with early-stage uterine (endometrial) cancer and a BMI of 30 or higher. The goal is to see which approach is safer and works better for this group.
RomeAges 18–75 - NCT06625996Recruiting
Carbs before surgery for faster recovery
This study looks at whether drinking carbohydrate-rich liquids before surgery helps you recover faster. It is for people with heart conditions, but not for those who need insulin for diabetes.
AsyutAges 18 years+ - NCT06626178Recruiting
AI for preventing smoking-related diseases
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
MilanAges 18 years+ - NCT06628336Recruiting
Study of HARMONY Evolution hip replacement implants
This study looks at how well HARMONY Evolution implants and tools work for people getting a total hip replacement. It will help doctors understand if the implants are safe and effective over time.
BesançonAges 18–99 - NCT07730450RecruitingPhase 4
COVID-19 vaccine study for healthy adults aged 18 to 64
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Walnut Creek, CaliforniaAges 18–64 - NCT07729579RecruitingPhase 1
Study of a drug for actinic keratosis on arms or face
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
College Station, TexasAges 18–85 - NCT07729852Enrolling by invitationPhase 2
Continuing access to ATH434 after the earlier study
This trial lets people who finished the earlier ATH434-201 study keep getting ATH434 (an experimental drug) on an open-label basis, meaning everyone knows they get the drug. If you were in that study and want to continue, this may help you keep receiving the treatment.
Toulouse, Midi-PyreneesAges Any age - NCT07726147RecruitingPhase 1
Testing a new allergy shot for Japanese cedar pollen
This trial tests a new allergy shot (ITI-9001) for people with Japanese cedar pollen allergy. It aims to see if the shot is safe and can reduce allergy symptoms. The study is for people who have not tried immunotherapy before.
Tokyo, Shinjuku-kuAges 18–65 - NCT07727057Recruiting
New catheter treatment for dangerous heart rhythm problems
This study tests a new catheter-based treatment for people with certain types of very fast or extra heartbeats that come from the lower chambers of the heart. The catheter uses a special energy to stop the abnormal beats and might help if you have had symptoms despite other treatments.
LinzAges 18 years+ - NCT07729956RecruitingPhase 3
Study of BL-B01D1 plus immunotherapy for advanced triple-negative breast cancer
This trial tests a new drug called BL-B01D1 combined with an immunotherapy (PD-1 antibody) against a standard chemo/immu-notherapy combination. It is for people with previously untreated, advanced triple-negative breast cancer whose tumors have a protein called PD-L1.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07723833RecruitingPhase 1
Study of different forms of elecoglipron in healthy volunteers
This trial tests how different versions of the drug elecoglipron are absorbed by the body and if they are safe. It is for healthy people to help find the best way to take the medicine.
Glendale, CaliforniaAges 18–55 - NCT07729943Recruiting
Ginseng & Cordyceps for Better Exercise Performance
This trial tests whether a combination of ginseng and cordyceps (a type of mushroom) can help improve how well your body uses oxygen during exercise. It's for healthy, active adults aged 40 to 65 who want to see if these natural ingredients can boost stamina and recovery.
Canfield, OhioAges 40–65 - NCT07730021RecruitingPhase 1/Phase 2
New drug for advanced solid tumors
This trial tests a new drug called ASP388B, given alone or with standard treatments, for people with certain advanced solid tumors that have stopped responding to therapy. It may help shrink tumors or slow their growth.
Lake Success, New YorkAges 18 years+ - NCT07728487RecruitingPhase 1
AT-587 safety study in healthy volunteers
This trial tests a new medication called AT-587 in healthy people to see if it is safe and how the body processes it. You may help by participating if you are in good health and meet the basic requirements.
EdegemAges 18–65 - NCT07723963RecruitingPhase 2/Phase 3
Study of JZP926 for juvenile myoclonic epilepsy
This study tests an investigational drug called JZP926 (a type of cannabinoid) to see if it can reduce the number of days with myoclonic seizures in people with juvenile myoclonic epilepsy. If you have this condition and are at least 10 years old, you might be able to join.
Phoenix, ArizonaAges 10 years+ - NCT07724756RecruitingPhase 2
Testing QLC2519 with chemotherapy for pediatric sarcoma
This trial tests a new drug (QLC2519) given alongside a standard chemotherapy regimen called VDC/IE for children and teens with sarcoma. The goal is to see if it can help treat their cancer more effectively.
BeijingAges birth–18 years - NCT07725237Recruiting
Double scan for clearer imaging results
This study tests whether having an extra SPECT/CT scan provides clearer images. If you already need a SPECT/CT scan, you may be able to join, and the extra scan might help improve imaging technology.
HaifaAges 18 years+ - NCT07726992RecruitingPhase 3
New drug plus BCG for high-risk bladder cancer
This study tests a new immunotherapy drug (SHR-1501) combined with standard BCG therapy for people with a specific type of early bladder cancer (papillary-only, high-risk). The goal is to see if the combination helps prevent cancer from returning better than BCG alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07730515RecruitingPhase 1/Phase 2
Study of XNW5004 plus chemo for untreated T-cell lymphoma
This trial tests a new drug called XNW5004 combined with standard chemotherapy for people who have just been diagnosed with peripheral T-cell lymphoma and haven't had treatment yet. The goal is to see if adding XNW5004 helps more than chemotherapy alone.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07729137RecruitingPhase 2
Eye cell therapy for corneal swelling
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
Torrance, CaliforniaAges 21 years+ - NCT07732400RecruitingPhase 1/Phase 2
Gene therapy for MASH (fatty liver disease)
This trial tests an experimental gene therapy (VV-14303) given as a single injection into the muscle to treat MASH, a common type of fatty liver disease with inflammation. The study will check if the treatment is safe and helps improve liver health.
Chandler, ArizonaAges 18–75 - NCT07725796RecruitingPhase 1
Study of UGN-501 for recurrent bladder cancer
This study tests an experimental medicine called UGN-501 given directly into the bladder. It is for people whose bladder cancer has come back despite previous treatments, such as BCG therapy. The goal is to find the best dose and see how safe and effective it is.
Queen Creek, ArizonaAges 18 years+ - NCT07732023RecruitingPhase 1
Study of a new asthma medication compared to placebo
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Chengdu, SichuanAges 18–70
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,511 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.